Views & Analysis The continuing rise of patient-centrists (and how we can hel... Communications agencies can assist pharma in putting the patient at the heart of business.
Views & Analysis Patient-centric trials – dream or reality? Many pharma companies claim to put patients at the heart of research, but how many live up to these expectations?
Views & Analysis From treatment to technology: a personal journey William King, founder and executive chairman of Zephyr Health, on using predictive insights for business transformation.
Views & Analysis IBM Watson: a holistic approach to health Kyu Rhee, chief health officer, speaks about the company's impact and aspirations in health.
Articles EFPIA’s director general, Richard Bergström, on market acces... He says the industry will partner with payers to deliver outcomes-driven, sustainable healthcare, in pharmaphorum's magazine Deep Dive: Market Access.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.